Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening

Gastrointestinal Endoscopy

Volumn 85, Issue 3, 2017, Pages 657-665.e1

  Johnson, David H ^a   Kisiel, John B ^a   Burger, Kelli N ^a   Mahoney, Douglas W ^a   Devens, Mary E ^a   Ahlquist, David A ^a   Sweetser, Seth ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; DNA; K RAS PROTEIN; OSTEOGENIN;

ANEMIA; CANCER SCREENING; CLINICAL TRIAL (TOPIC); COLON POLYPOSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; COLORECTAL TUMOR; CONFERENCE PAPER; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOSCOPIST; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RECTUM ADENOMA; ADENOMA; AGED; CARCINOMA; CHEMISTRY; COLONIC POLYPS; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FECES; GENETICS; MIDDLE AGED;

ADENOMA; AGED; CARCINOMA; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA; DNA, NEOPLASM; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 85008204235     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2016.11.012     Document Type: Conference Paper

References (46)

1. 1 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J Clin 65 (2015), 5–29.
2. 2 Siegel, R.L., Ward, E.M., Jemal, A., Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev 21 (2012), 411–416.
3. 3 Hewett, D.G., Kahi, C.J., Rex, D.K., Does colonoscopy work?. J Natl Compr Canc Netw 8 (2010), 67–76 quiz 77.
4. 4 Baxter, N.N., Warren, J.L., Barrett, M.J., et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 30 (2012), 2664–2669.
5. 5 Klabunde, C.N., Cronin, K.A., Breen, N., et al. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev 20 (2011), 1611–1621.
6. 6 Steinwachs, D., Allen, J.D., Barlow, W.E., et al. National Institutes of Health state-of-the-science conference statement: enhancing use and quality of colorectal cancer screening. Ann Intern Med 152 (2010), 663–667.
7. 7 Rex, D.K., Johnson, D.A., Anderson, J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. [corrected] Am J Gastroenterol 104 (2009), 739–750.
8. 8 Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008), 1570–1595.
9. 9 Screening for Colorectal Cancer: U.S. Preventive Services Task Force recommendation statement screening for colorectal cancer. Ann Intern Med 149 (2008), 627–637.
10. 10 Steele, C.B., Rim, S.H., Joseph, D.A., et al. Colorectal cancer incidence and screening—United States, 2008 and 2010. MMWR Surveill Summ 62:Suppl 3 (2013), 53–60.
11. 11 Kahi, C.J., Imperiale, T.F., Juliar, B.E., et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 7 (2009), 770–775 quiz 711.
12. 12 Nishihara, R., Wu, K., Lochhead, P., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369 (2013), 1095–1105.
13. 13 Baxter, N.N., Goldwasser, M.A., Paszat, L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150 (2009), 1–8.
14. 14 Robertson, D.J., Lieberman, D.A., Winawer, S.J., et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut 63 (2014), 949–956.
15. 15 Leggett, B., Whitehall, V., Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138 (2010), 2088–2100.
16. 16 Kahi, C.J., Hewett, D.G., Norton, D.L., et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 9 (2011), 42–46.
17. 17 Corley, D.A., Jensen, C.D., Marks, A.R., et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370 (2014), 1298–1306.
18. 18 Kaminski, M.F., Regula, J., Kraszewska, E., et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362 (2010), 1795–1803.
19. 19 Butterly, L., Robinson, C.M., Anderson, J.C., et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol 109 (2014), 417–426.
20. 20 Barclay, R.L., Vicari, J.J., Doughty, A.S., et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 355 (2006), 2533–2541.
21. 21 Benson, M.E., Reichelderfer, M., Said, A., et al. Variation in colonoscopic technique and adenoma detection rates at an academic gastroenterology unit. Dig Dis Sci 55 (2010), 166–171.
22. 22 Rex, D.K., Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc 51 (2000), 33–36.
23. 23 Rex, D.K., Petrini, J.L., Baron, T.H., et al. Quality indicators for colonoscopy. Gastrointest Endosc 63 (2006), S16–S28.
24. 24 Rex, D.K., Schoenfeld, P.S., Cohen, J., et al. Quality indicators for colonoscopy. Am J Gastroenterol 110 (2015), 72–90.
25. 25 Subramanian, S., Klosterman, M., Amonkar, M.M., et al. Adherence with colorectal cancer screening guidelines: a review. Prev Med 38 (2004), 536–550.
26. 26 Ferrante, J.M., Ohman-Strickland, P., Hahn, K.A., et al. Self-report versus medical records for assessing cancer-preventive services delivery. Cancer Epidemiol Biomarkers Prev 17 (2008), 2987–2994.
27. 27 Inadomi, J.M., Vijan, S., Janz, N.K., et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172 (2012), 575–582.
28. 28 Liang, P.S., Wheat, C.L., Abhat, A., et al. Adherence to competing strategies for colorectal cancer screening over 3 years. Am J Gastroenterol 111 (2016), 105–114.
29. 29 Moawad, F.J., Maydonovitch, C.L., Cullen, P.A., et al. CT colonography may improve colorectal cancer screening compliance. AJR Am J Roentgenol 195 (2010), 1118–1123.
30. 30 Gluecker, T.M., Johnson, C.D., Harmsen, W.S., et al. Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology 227 (2003), 378–384.
31. 31 Imperiale, T.F., Ransohoff, D.F., Itzkowitz, S.H., et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370 (2014), 1287–1297.
32. 32 Redwood, D.G., Asay, E.D., Blake, I.D., et al. Stool DNA testing for screening detection of colorectal neoplasia in Alaska native people. Mayo Clin Proc 91 (2016), 61–70.
33. 33 Berger, B.M., Hooker, A., Bethke, L., et al. Colorectal cancer screening with multi-target stool DNA-based testing: previous screening history of the initial patient cohort. Am J Gastroenterol, 110, 2015, S607.
34. 34 Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 37 (2005), 570–578.
35. 35 Lieberman, D.A., Williams, J.L., Holub, J.L., et al. Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals. Gastroenterology 147 (2014), 351–358 quiz e14-5.
36. 36 Lieberman, D.A., Holub, J., Eisen, G., et al. Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol 3 (2005), 798–805.
37. 37 Lieberman, D.A., Holub, J.L., Moravec, M.D., et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 300 (2008), 1417–1422.
38. 38 Lee, B., Holub, J., Peters, D., et al. Prevalence of colon polyps detected by colonoscopy screening of asymptomatic Hispanic patients. Dig Dis Sci 57 (2012), 481–488.
39. 39 Regula, J., Rupinski, M., Kraszewska, E., et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 355 (2006), 1863–1872.
40. 40 Schroy, P.C. 3rd, Coe, A., Chen, C.A., et al. Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med 159 (2013), 13–20.
41. 41 Brenner, H., Hoffmeister, M., Arndt, V., et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102 (2010), 89–95.
42. 42 Saini, S.D., Kim, H.M., Schoenfeld, P., Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 64 (2006), 614–626.
43. 43 Kahi, C.J., Vemulapalli, K.C., Johnson, C.S., et al. Improving measurement of the adenoma detection rate and adenoma per colonoscopy quality metric: the Indiana University experience. Gastrointest Endosc 79 (2014), 448–454.
44. 44 Shaukat, A., Rector, T.S., Church, T.R., et al. Longer withdrawal time is associated with a reduced incidence of interval cancer after screening colonoscopy. Gastroenterology 149 (2015), 952–957.
45. 45 Vavricka, S.R., Sulz, M.C., Degen, L., et al. Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists. Endoscopy 48 (2016), 256–262.
46. 46 Greenspan, M., Chehl, N., Shawron, K., et al. Patient non-adherence and cancellations are higher for screening colonoscopy compared with surveillance colonoscopy. Dig Dis Sci 60 (2015), 2930–2936.